Nurix Therapeutics, Inc.
NRIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001549595
In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Nurix Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 182
- +11 vs. Q3 2025
- Shares held
- 113.4M
- +29.0M (+34.3%) vs. Q3 2025
- Total value
- $2.15B
- +$1.37B (+175.7%) vs. Q3 2025
- New holders
- 39
- 93 more added
- Sold out
- 28
- 29 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $2.84B |
| Q1 2026 | 196 | $1.81B |
| Q4 2025 | 182 | $2.15B |
| Q3 2025 | 173 | $783.3M |
| Q2 2025 | 164 | $1.01B |
| Q1 2025 | 170 | $1.01B |
| Q4 2024 | 175 | $1.53B |
| Q3 2024 | 172 | $1.53B |
| Q2 2024 | 174 | $1.36B |
| Q1 2024 | 139 | $721.3M |
| Q4 2023 | 131 | $475.6M |
| Q3 2023 | 129 | $352.5M |
| Q2 2023 | 126 | $435.7M |
| Q1 2023 | 124 | $376.6M |
| Q4 2022 | 119 | $468.6M |
| Q3 2022 | 118 | $561.0M |
| Q2 2022 | 106 | $568.4M |
| Q1 2022 | 117 | $565.6M |
| Q4 2021 | 125 | $1.17B |
| Q3 2021 | 113 | $1.18B |
| Q2 2021 | 104 | $1.05B |
| Q1 2021 | 101 | $1.29B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Magnetar Financial LLC | 0 | $0 | 0.00% | −22,535−100.0% | Sold out |
| BBR Partners, LLC | 0 | $0 | 0.00% | −20,988−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,492−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −16,210−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −14,272−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,754−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −10,817−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,020−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −4,487−100.0% | Sold out |
| J.Safra Asset Management Corp | 0 | $0 | 0.00% | −158−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |